Literature DB >> 20425615

PPARs in bone: the role in bone cell differentiation and regulation of energy metabolism.

Beata Lecka-Czernik1.   

Abstract

Obesity, diabetes, and osteoporosis are major public health concerns. Current estimates indicate that the US population consists of 25% obese, 30% diabetic and prediabetic, and, among the elderly, 50% of all osteoporotic individuals. Mechanistically, these pathologies share several features including common regulators of bone homeostasis and energy metabolism. Peroxisome proliferator-activated receptors (PPARs) represent a family of proteins that control energy turnover in adipose, liver, and muscle tissue. These proteins also control bone turnover and regulate bone cell differentiation. Recent evidence suggests that bone is an organ integral to energy metabolism not only with respect to energy storage, but also as an organ regulating systemic energy homeostasis. In this article, we review current knowledge on the role of PPARs in bone metabolism and bone cell differentiation. We also discuss the role of bone fat in modulation of bone marrow microenvironment and its possible contribution to the systemic regulation of energy metabolism.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20425615     DOI: 10.1007/s11914-010-0016-1

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  52 in total

Review 1.  Playing with bone and fat.

Authors:  Jeffrey M Gimble; Sanjin Zvonic; Z Elizabeth Floyd; Moustapha Kassem; Mark E Nuttall
Journal:  J Cell Biochem       Date:  2006-05-15       Impact factor: 4.429

2.  Differential expression of cytokines in subcutaneous and marrow fat of aging C57BL/6J mice.

Authors:  Marco Gasparrini; Daniel Rivas; Alexandre Elbaz; Gustavo Duque
Journal:  Exp Gerontol       Date:  2009-06-06       Impact factor: 4.032

Review 3.  Marrow adipose cells and hemopoiesis: an interpretative review.

Authors:  M Tavassoli
Journal:  Exp Hematol       Date:  1984-02       Impact factor: 3.084

4.  Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity.

Authors:  Yong-Xu Wang; Chih-Hao Lee; Sambath Tiep; Ruth T Yu; Jungyeob Ham; Heonjoong Kang; Ronald M Evans
Journal:  Cell       Date:  2003-04-18       Impact factor: 41.582

5.  Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways.

Authors:  Yusuke Shinoda; Masayuki Yamaguchi; Naoshi Ogata; Toru Akune; Naoto Kubota; Toshimasa Yamauchi; Yasuo Terauchi; Takashi Kadowaki; Yasuhiro Takeuchi; Seiji Fukumoto; Toshiyuki Ikeda; Kazuto Hoshi; Ung-il Chung; Kozo Nakamura; Hiroshi Kawaguchi
Journal:  J Cell Biochem       Date:  2006-09-01       Impact factor: 4.429

6.  Skeletal consequences of deletion of steroid receptor coactivator-2/transcription intermediary factor-2.

Authors:  Ulrike I Mödder; David G Monroe; Daniel G Fraser; Thomas C Spelsberg; Clifford J Rosen; Martine Géhin; Pierre Chambon; Bert W O'Malley; Sundeep Khosla
Journal:  J Biol Chem       Date:  2009-05-07       Impact factor: 5.157

Review 7.  The important role of lipid peroxidation processes in aging and age dependent diseases.

Authors:  Gerhard Spiteller
Journal:  Mol Biotechnol       Date:  2007-09       Impact factor: 2.695

Review 8.  Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis.

Authors:  Philippe Lefebvre; Giulia Chinetti; Jean-Charles Fruchart; Bart Staels
Journal:  J Clin Invest       Date:  2006-03       Impact factor: 14.808

9.  Endocrine regulation of energy metabolism by the skeleton.

Authors:  Na Kyung Lee; Hideaki Sowa; Eiichi Hinoi; Mathieu Ferron; Jong Deok Ahn; Cyrille Confavreux; Romain Dacquin; Patrick J Mee; Marc D McKee; Dae Young Jung; Zhiyou Zhang; Jason K Kim; Franck Mauvais-Jarvis; Patricia Ducy; Gerard Karsenty
Journal:  Cell       Date:  2007-08-10       Impact factor: 41.582

10.  Enhanced marrow adipogenesis and bone resorption in estrogen-deprived rats treated with the PPARgamma agonist BRL49653 (rosiglitazone).

Authors:  V Sottile; K Seuwen; M Kneissel
Journal:  Calcif Tissue Int       Date:  2004-07-13       Impact factor: 4.333

View more
  17 in total

Review 1.  Marrow fat metabolism is linked to the systemic energy metabolism.

Authors:  Beata Lecka-Czernik
Journal:  Bone       Date:  2011-07-04       Impact factor: 4.398

2.  Skeletal aging and the adipocyte program: New insights from an "old" molecule.

Authors:  Beata Lecka-Czernik; Clifford J Rosen; Masanobu Kawai
Journal:  Cell Cycle       Date:  2010-09-15       Impact factor: 4.534

Review 3.  The interrelationship between bone and fat: from cellular see-saw to endocrine reciprocity.

Authors:  H Sadie-Van Gijsen; N J Crowther; F S Hough; W F Ferris
Journal:  Cell Mol Life Sci       Date:  2012-11-21       Impact factor: 9.261

Review 4.  Adipose tissue dysfunction and its effects on tumor metabolism.

Authors:  Jonathan Diedrich; Halina Chkourko Gusky; Izabela Podgorski
Journal:  Horm Mol Biol Clin Investig       Date:  2015-01

5.  Protective effects of fish intake and interactive effects of long-chain polyunsaturated fatty acid intakes on hip bone mineral density in older adults: the Framingham Osteoporosis Study.

Authors:  Emily K Farina; Douglas P Kiel; Ronenn Roubenoff; Ernst J Schaefer; L Adrienne Cupples; Katherine L Tucker
Journal:  Am J Clin Nutr       Date:  2011-03-02       Impact factor: 7.045

Review 6.  Bone marrow fat: linking adipocyte-induced inflammation with skeletal metastases.

Authors:  Aimalie L Hardaway; Mackenzie K Herroon; Erandi Rajagurubandara; Izabela Podgorski
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

7.  Marrow adipocyte-derived CXCL1 and CXCL2 contribute to osteolysis in metastatic prostate cancer.

Authors:  Aimalie L Hardaway; Mackenzie K Herroon; Erandi Rajagurubandara; Izabela Podgorski
Journal:  Clin Exp Metastasis       Date:  2015-03-24       Impact factor: 5.150

8.  Rosiglitazone inhibits bone regeneration and causes significant accumulation of fat at sites of new bone formation.

Authors:  Lichu Liu; James Aronson; Shilong Huang; Yalin Lu; Piotr Czernik; Sima Rahman; Vipula Kolli; Larry J Suva; Beata Lecka-Czernik
Journal:  Calcif Tissue Int       Date:  2012-07-01       Impact factor: 4.333

9.  Rosiglitazone disrupts endosteal bone formation during distraction osteogenesis by local adipocytic infiltration.

Authors:  Lichu Liu; James Aronson; Beata Lecka-Czernik
Journal:  Bone       Date:  2012-10-13       Impact factor: 4.398

Review 10.  Effects of nutrition and alcohol consumption on bone loss.

Authors:  Martin J J Ronis; Kelly Mercer; Jin-Ran Chen
Journal:  Curr Osteoporos Rep       Date:  2011-06       Impact factor: 5.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.